Peer Review History
| Original SubmissionOctober 13, 2022 |
|---|
|
PONE-D-22-28279COVID-19 Stress Syndrome in the German general population: Validation of a German version of the COVID Stress ScalesPLOS ONE Dear Dr. Jungmann, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== One expert reviewer in the field of psychometrics has reviewed the work and provided some comments for revision. I agree with the opinions from the reviewer that the present contribution in general is good. However, it needs to be revised before publication. Apart from the reviewer's comments, the authors should consider the following of my concerns as well.1. I think that the authors did not provide a figure legend to explain their figure 1. Specifically, the authors have used some abbreviations in the figure 1 and their figure legend should explain these abbreviations because figure should stand alone.2. The authors mentioned the abbreviation of RMSEA in the Abstract without providing a full spell-out. Given that Abstract also stands alone to the main text, the full spell-out of the RMSEA should be given in the Abstract.3. This may be a stylish issue; however, I prefer the authors report the full spell-out of the abbreviations and put the abbreviations in the brackets. Instead of reporting the abbreviations and putting the full spell-outs in the brackets.4. The Introduction has used some systematic reviews to describe the mental health issues during COVID-19; however, I would encourage the authors further using the following systematic reviews and large-scale studies to strengthen the descriptions.Khankeh H, Pourebrahimi M, Karibozorg MF, Hosseinabadi-Farahani M, Ranjbar M, Ghods MJ, Saatchi M. Public trust, preparedness, and the influencing factors regarding COVID-19 pandemic situation in Iran: A population-based cross-sectional study. Asian J Soc Health Behav 2022;5:154-61Vicerra PM. Mental stress and well-being among low-income older adults during COVID-19 pandemic. Asian J Soc Health Behav 2022;5:101-7Hasannia E, Mohammadzadeh F, Tavakolizadeh M, Davoudian N, Bay M. Assessment of the anxiety level and trust in information resources among iranian health-care workers during the pandemic of coronavirus disease 2019. Asian J Soc Health Behav 2021;4:163-8Olashore AA, Akanni OO, Fela-Thomas AL, Khutsafalo K. The psychological impact of COVID-19 on health-care workers in African Countries: A systematic review. Asian J Soc Health Behav 2021;4:85-97Rajabimajd N, Alimoradi Z, Griffiths MD. Impact of COVID-19-related fear and anxiety on job attributes: A systematic review. Asian J Soc Health Behav 2021;4:51-55. This statement "prove to be as reliable (ω > .80)" should be revised. Although many people consider that internal consistency is a type of reliability; its nature is more like validity (i.e., all items are associated with each other). Therefore, I would use test-retest reliability to emphasize if the tested instrument (i.e., CSS) is reliable. The hypothesis of ω here is fine, but it would be much better if test-retest reliability is also hypothesized.6. I prefer the authors not using some strong words (e.g., prove) in the present submission.7. As the present sample included some participants aged below 18 years, I wonder if the authors have obtained their parents' informed consent. 8. The authors did a chi-square difference test; however, this is not mentioned in their Statistical analysis section. Although some people know that the DIFFTEST option in Mplus is used for chi-square difference test, not everybody knows this. Please clearly mention this in the Statistical analysis section.9. The authors have compared the correlation coefficients; however, this is not stated in the Statistical analysis section either. I think that the authors have used Lee & Preacher's website to make the correlation coefficient comparisons. However, they did not disclose this. Or, if I get it wrong, the authors should provide a proper citation to indicate how they compared the correlation coefficients. ============================== Please submit your revised manuscript by Jan 15 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Chung-Ying Lin Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the opportunity to review this work. The authors attempted to validate the German version of COVID Stress Scales. The validation would be advantageous to the target population. However, there are a few small issues that need to be addressed. 1. Line 115, it is more appropriate to say “translate and validate” rather than “develop and validate”. 2. Lines 142-143, what is the meaning of "denied the inclusion criteria"? 3. Line 146, “26.6% m, 73.4% f”. Please use “male” and “female”. 4. Please provide the reliability of PHQ-4, SHAI, OCI-R(wash), PTSD-Screening, Xenophobia Scale in current study. 5. Line 203, What is the purpose of PHQ-4 in time point 2? 6. In statistical analyses, description about convergent and discriminant validity was missing. 7. In results, it would be better to report “descriptive statistics, inter-correlations, and reliability” before “Factor structure”. 8. Line 289, again, it is more appropriate to say “translate and validate” rather than “develop and validate”. 9. Lines 310–312, the use of square brackets may confuse readers. For example, [descriptively slightly lower values, 20], readers may think 20 is the value, but it is the citation. Use round bracket is fine, i.e. (descriptively slightly lower values) [20]. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
COVID-19 Stress Syndrome in the German general population: Validation of a German version of the COVID Stress Scales PONE-D-22-28279R1 Dear Dr. Jungmann, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Chung-Ying Lin Academic Editor PLOS ONE Additional Editor Comments (optional): I have evaluated the authors' responses to the reviewer's comments and my comments. The authors have satisfactorily addressed all the comments and improve the manuscript satisfactorily. I applaud and thank for the authors' efforts in this contribution and am happy to accept this contribution. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-28279R1 COVID-19 Stress Syndrome in the German general population: Validation of a German version of the COVID Stress Scales Dear Dr. Jungmann: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Chung-Ying Lin Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .